Charles River Laboratories CRL Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $995.83M+0.2% | $994.23M-1.1% | $1B-2.6% | $1.03B+4.9% | $984.17M-1.8% | ||
| $12.2M-7.6% | $13.2M+9.1% | $12.1M0.0% | $12.1M+4.3% | $11.6M-21.1% | ||
| $159.42M-18.7% | $196.14M+10.4% | $177.59M-7.3% | $191.55M+7.7% | $177.8M-9.2% | ||
| $22.38M+26.9% | $17.63M-24.2% | $23.27M+36.5% | $17.05M+29.8% | $13.14M-23.8% | ||
| $67.15M-14.2% | $78.28M-8.1% | $85.16M-28.7% | $119.51M-0.7% | $120.36M+17.9% | ||
| $47K-96.9% | $1.5M-36.5% | $2.37M+1,187% | $184K-90.8% | $2.01M-69.4% | ||
| $31.58M+19.2% | $26.49M+53.2% | $17.28M-46.3% | $32.2M+35.0% | $23.85M-42.4% | ||
| —— | $41.25M0.0% | $41.25M0.0% | $41.25M0.0% | $41.25M-23.3% | ||
| $15.86M-92.9% | $222.9M+4,374% | $4.98M-75.8% | $20.63M+95.0% | $10.58M-69.3% | ||
| $119.9M— | —— | $133.8M+33.6% | $100.13M+34.1% | $74.67M— | ||
| 12%— | —— | 13.3%+3.6pp | 9.7%+2.1pp | 7.6%— | ||
| $26.74M+12.5% | $23.78M-6.4% | $25.4M-15.2% | $29.97M+7.5% | $27.88M-1.2% | ||
| $1.03M+1.6% | $1.02M-28.5% | $1.42M+29.6% | $1.1M-21.9% | $1.4M-23.5% | ||
| -$124.13M— | —— | -$22.62M-14,787% | $154K+101% | -$12.21M+46.2% | ||
| -$117.98M— | —— | —— | —— | $3.38M— | ||
| -$15.14M— | —— | $31.64M+69.0% | $18.73M+85.4% | $10.1M— | ||
| -$14.84M+94.6% | -$276.56M-608% | $54.42M+4.0% | $52.33M+105% | $25.47M— | ||
| -1.5%+26.3pp | -27.8%-33.2pp | 5.4%+0.3pp | 5.1%+2.5pp | 2.6%— | ||
| $41K-84.5% | $265K-76.6% | $1.13M+209% | $367K-10.3% | $409K-45.3% | ||
| -$0.30+94.6% | -$5.56-605% | $1.10+3.8% | $1.06+112% | $0.50— | ||
| -$0.30+94.6% | -$5.57-602% | $1.11+4.7% | $1.06+112% | $0.50— | ||
| 49M-1.2% | 49.6M+0.3% | 49.4M+0.2% | 49.3M-3.0% | 50.9M-1.5% | ||
| 49M-1.2% | 49.6M+0.7% | 49.2M+0.1% | 49.1M-3.0% | 50.7M-1.4% | ||
| $47K-96.9% | $1.5M-36.5% | $2.37M+1,187% | $184K-90.8% | $2.01M-69.4% | ||
| -$500K-156% | $900K-50.0% | $1.8M— | —— | $1.5M-73.7% | ||
| $8.3M+4,050% | $200K— | $0-100% | $6.8M+119% | $3.1M+3,000% | ||
| $22.38M+26.9% | $17.63M-24.2% | $23.27M+36.5% | $17.05M+29.8% | $13.14M-23.8% | ||
| $2.4M-50.5% | $4.85M+246% | $1.4M-61.1% | $3.6M-11.0% | $4.05M-66.6% | ||
| $15.35M-27.0% | $21.01M-23.3% | $27.4M-58.1% | $65.38M+0.2% | $65.26M+58.3% | ||
| $0— | —— | $7.4M+76.2% | $4.2M-32.3% | $6.2M— | ||
| —— | $1.89M0.0% | $1.89M0.0% | $1.89M0.0% | $1.89M-2.7% | ||
| 615K-33.0% | 918K-18.8% | 1.1M+0.3% | 1.1M+17.7% | 958K+80.8% | ||
| -$17.8M-363% | $6.78M-72.3% | $24.48M+152% | -$46.99M-280% | $26.16M+531% | ||
| -$34.1M— | —— | $29.27M-80.6% | $151.11M+94.8% | $77.57M+123% | ||
| -$393K-354% | $155K-78.9% | $735K-74.6% | $2.89M+745% | -$449K-131% | ||
| -$34.5M— | —— | $30.01M-80.5% | $154M+99.7% | $77.12M+123% | ||
| 75%-15.0% | 90%— | —— | —— | 70%-20.0% | ||
| 55%-25.0% | 80%— | —— | —— | 60%-20.0% | ||
| —— | $2.72M0.0% | $2.72M0.0% | $2.72M0.0% | $2.72M-70.1% | ||
| —— | $24.36M0.0% | $24.36M0.0% | $24.36M0.0% | $24.36M+12.6% | ||
| —— | $2.43M0.0% | $2.43M0.0% | $2.43M0.0% | $2.43M-20.1% | ||
| —— | $850K0.0% | $850K0.0% | $850K0.0% | $850K+13.3% | ||
| —— | -$10.19M0.0% | -$10.19M0.0% | -$10.19M0.0% | -$10.19M+19.4% | ||
| —— | -$5.6M0.0% | -$5.6M0.0% | -$5.6M0.0% | -$5.6M-224% | ||
| —— | -$18.84M0.0% | -$18.84M0.0% | -$18.84M0.0% | -$18.84M-12.2% | ||
| -$29.42M+51.1% | -$60.17M— | —— | -$21.99M-15.5% | -$19.04M+54.1% | ||
| —— | -$3.05M0.0% | -$3.05M0.0% | -$3.05M0.0% | -$3.05M-25.5% | ||
| —— | $3.28M0.0% | $3.28M0.0% | $3.28M0.0% | $3.28M+1,258% | ||
| —— | $9.1M0.0% | $9.1M0.0% | $9.1M0.0% | $9.1M+320% | ||
| —— | -$3.23M0.0% | -$3.23M0.0% | -$3.23M0.0% | -$3.23M— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $1.21M0.0% | $1.21M0.0% | $1.21M0.0% | $1.21M+131% | ||
| —— | $2.08M0.0% | $2.08M0.0% | $2.08M0.0% | $2.08M-22.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | 5.2%— | —— | —— | —— | ||
| —— | $0.010.0% | $0.010.0% | $0.010.0% | $0.01+25.7% | ||
| —— | 3.2%— | —— | —— | —— | ||
| —— | $1.81M0.0% | $1.81M0.0% | $1.81M0.0% | $1.81M-10.1% | ||
| —— | $497.75K0.0% | $497.75K0.0% | $497.75K0.0% | $497.75K-63.8% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | -$3.38M0.0% | -$3.38M0.0% | -$3.38M0.0% | -$3.38M-502% | ||
| —— | -$7.25K0.0% | -$7.25K0.0% | -$7.25K0.0% | -$7.25K— | ||
| —— | $1.81M0.0% | $1.81M0.0% | $1.81M0.0% | $1.81M-10.1% | ||
| —— | $3.48M0.0% | $3.48M0.0% | $3.48M0.0% | $3.48M+618% | ||
| —— | $3.5K0.0% | $3.5K0.0% | $3.5K0.0% | $3.5K— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $6.73M0.0% | $6.73M0.0% | $6.73M0.0% | $6.73M-12.9% | ||
| —— | 25%— | —— | —— | —— | ||
| —— | 10%— | —— | —— | —— | ||
| $41.3M-8.4% | $45.1M+0.7% | $44.8M+1.1% | $44.3M+2.1% | $43.4M-10.3% | ||
| $1.25M-68.2% | $3.93M— | —— | $12.67M+141% | $5.27M+139% | ||
| $0.51+168% | -$0.74-304% | $0.36+38.5% | $0.26-6.8% | $0.28-43.7% | ||
| —— | 21%— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $4.25K0.0% | $4.25K0.0% | $4.25K0.0% | $4.25K— | ||
| —— | 0%— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $1.57M0.0% | $1.57M0.0% | $1.57M0.0% | $1.57M— | ||
| —— | -6.3%— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | -$0.010.0% | -$0.010.0% | -$0.010.0% | -$0.01— | ||
| —— | -5%— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $1.24M0.0% | $1.24M0.0% | $1.24M0.0% | $1.24M— | ||
| —— | -4.5%— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | 2.7%— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$117.98M— | —— | —— | —— | $3.38M— | ||
| $38.5M— | —— | —— | —— | —— | ||
| $340.99M— | —— | —— | —— | —— | ||
| -$18.55M-366% | $6.97M— | —— | $62.86M+104% | $30.79M+149% | ||
| —— | $41.25M0.0% | $41.25M0.0% | $41.25M0.0% | $41.25M-23.3% | ||
| $46.65M— | —— | —— | —— | $4M— | ||
| $15.86M-92.9% | $222.9M+4,374% | $4.98M-75.8% | $20.63M+95.0% | $10.58M-69.3% | ||
| —— | -$72.66M0.0% | -$72.66M0.0% | -$72.66M0.0% | -$72.66M-0.1% | ||
| —— | $47.79M0.0% | $47.79M0.0% | $47.79M0.0% | $47.79M-50.1% | ||
| -$29.94M+89.8% | -$294.1M-437% | $87.2M+22.1% | $71.42M+98.5% | $35.98M— | ||
| —— | $10.57M0.0% | $10.57M0.0% | $10.57M0.0% | $10.57M— | ||
| —— | -$5.22M0.0% | -$5.22M0.0% | -$5.22M0.0% | -$5.22M— | ||
| —— | $972K0.0% | $972K0.0% | $972K0.0% | $972K— | ||
| —— | $1.12M0.0% | $1.12M0.0% | $1.12M0.0% | $1.12M— | ||
| $1.73M-93.6% | $26.95M+44.1% | $18.7M-67.0% | $56.66M+227% | $17.32M-45.0% | ||
| $20.46M— | —— | $24.51M— | —— | $25.25M+452% | ||
| $65.32M+336% | -$27.63M-3.9% | -$26.6M-145% | -$10.86M-137% | $29.35M+986% | ||
| -$135K-101% | $15.19M+1,479% | -$1.1M— | —— | $9.17M— | ||
| $5.2M+120% | -$25.82M-9.3% | -$23.63M-289% | $12.52M+1,132% | -$1.21M-124% | ||
| -$83.76M— | $0-100% | $42.88M+80.7% | $23.73M+55.5% | $15.26M+160% | ||
| -$26M-844% | $3.5M-88.8% | $31.33M— | —— | $21.88M+826% | ||
| $8.52M— | —— | $43.07M+64.0% | $26.26M+748% | -$4.05M-132% | ||
| $131.4M— | —— | $800K-38.5% | $1.3M+44.4% | $900K— | ||
| $0+100% | -$186K-187% | $213K+27.5% | $167K-5.1% | $176K— | ||
| —— | $500K0.0% | $500K0.0% | $500K0.0% | $500K— | ||
| $28.99M+58.3% | $18.31M-35.3% | $28.29M+8.7% | $26.03M-10.5% | $29.09M+16.9% | ||
| —— | $6.13M0.0% | $6.13M0.0% | $6.13M0.0% | $6.13M-11.6% | ||
| $1.49M-14.8% | $1.75M— | $0-100% | $4.31M-36.3% | $6.76M-75.0% | ||
| $347.72M+770% | -$51.86M+66.0% | -$152.62M+32.7% | -$226.92M-115% | -$105.33M-38.8% | ||
| -$407.85M-339% | -$92.81M-175% | -$33.7M+9.8% | -$37.34M+17.9% | -$45.48M+40.2% | ||
| $41.08M-72.2% | $147.52M-31.0% | $213.83M+4.5% | $204.6M+19.2% | $171.7M+7.7% | ||
| $41K-84.5% | $265K-76.6% | $1.13M+209% | $367K-10.3% | $409K-45.3% | ||
| -$14.33M+94.8% | -$276.13M-603% | $54.94M+4.0% | $52.85M+105% | $25.8M— | ||
| $3.55M+49.3% | $2.38M+643% | $320K-86.6% | $2.38M+80.5% | $1.32M— | ||
| 3— | —— | —— | —— | 3— | ||
| -$25.18M-249% | $16.86M+163% | -$26.96M-122% | $121.22M+101% | $60.38M+146% | ||
| $894K— | —— | $462K+1.1% | $457K+12.0% | $408K-26.9% | ||
| -$24.29M-209% | $22.34M+184% | -$26.5M-122% | $121.68M+100% | $60.79M+143% | ||
| -$23.85M— | —— | —— | —— | —— | ||
| -$23.85M— | —— | —— | —— | —— | ||
| -$19.26M-197% | $19.83M+179% | -$25.15M-125% | $98.78M+89.6% | $52.1M+142% | ||
| —— | -$1.41M0.0% | -$1.41M0.0% | -$1.41M0.0% | -$1.41M-146% | ||
| -$4.59M-275% | $2.62M+375% | -$952K-105% | $20.37M+113% | $9.55M+151% | ||
| $34.68M— | —— | -$1.04M— | —— | -$3.73M+84.7% | ||
| -$124.13M— | —— | -$22.62M-14,787% | $154K+101% | -$12.21M+46.2% | ||
| $25.36M+76.0% | $14.41M+15.4% | $12.49M-56.1% | $28.47M+84.5% | $15.43M-46.2% | ||
| $0— | —— | —— | —— | $19.14M— | ||
| $1.46M+794% | -$210K+92.5% | -$2.81M-1,055% | -$243K-134% | -$104K+97.9% | ||
| $208.29M+216,864% | $96K+3.2% | $93K-98.7% | $7.35M-97.9% | $353.13M+284,684% | ||
| $17.3M+44.2% | $12M-14.2% | $13.99M-23.0% | $18.16M+26.8% | $14.32M-23.2% | ||
| $405.01M— | $0— | $0— | $0— | $0— | ||
| $8.49M+12.7% | $7.53M+69.1% | $4.45M+59.8% | $2.79M-47.4% | $5.3M-30.3% | ||
| $55.91M-37.1% | $88.95M+150% | $35.58M+0.8% | $35.3M-40.5% | $59.32M-21.5% | ||
| $912.46M+482% | $156.67M+45.7% | $107.5M-80.3% | $547.02M+31.4% | $416.34M+297% | ||
| -$2M-49.8% | -$1.34M+78.6% | -$6.23M+3.5% | -$6.46M— | $0+100% | ||
| $2.92M-15.7% | $3.47M-1.9% | $3.53M+601% | $504K-68.5% | $1.6M-27.7% | ||
| $60.1M— | —— | —— | —— | $17.44M— | ||
| $1.22M+72.0% | $711K+35,450% | $2K+100% | $1K— | $0-100% | ||
| —— | $3.75M0.0% | $3.75M0.0% | $3.75M0.0% | $3.75M— | ||
| $21.6M— | —— | —— | —— | —— | ||
| $47K-96.9% | $1.5M-36.5% | $2.37M+1,187% | $184K-90.8% | $2.01M-69.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $355.68M+71.1% | $207.82M-18.1% | $253.79M-65.6% | $738.31M+394% | $149.39M-15.5% | ||
| —— | $1.1M0.0% | $1.1M0.0% | $1.1M0.0% | $1.1M— | ||
| -$16.29M— | —— | -$5.88M+73.5% | -$22.16M-118% | -$10.16M— | ||
| -$284K— | —— | —— | $381K+310% | $93K+128% | ||
| $995.83M+0.2% | $994.23M-1.1% | $1B-2.6% | $1.03B+4.9% | $984.17M-1.8% | ||
| $1.91M— | $0-100% | $27K+108% | $13K— | $0-100% | ||
| $12.2M-7.6% | $13.2M+9.1% | $12.1M0.0% | $12.1M+4.3% | $11.6M-21.1% | ||
| $22.38M+26.9% | $17.63M-24.2% | $23.27M+36.5% | $17.05M+29.8% | $13.14M-23.8% | ||
| —— | 43%— | —— | —— | —— | ||
| —— | $61.63— | —— | —— | —— | ||
| —— | 21K— | —— | —— | —— | ||
| —— | $235.95— | —— | —— | —— | ||
| —— | 4.1%— | —— | —— | —— | ||
| —— | 40K— | —— | —— | —— | ||
| —— | 0%— | —— | —— | —— | ||
| —— | $135.00— | —— | —— | —— | ||
| —— | $179.66— | —— | —— | —— | ||
| $1.71M— | —— | —— | —— | $3.42M— | ||
| 100K0.0% | 100K— | —— | —— | 100K0.0% | ||
| —— | 1K— | —— | —— | —— | ||
| $1.22M+64.4% | $744K+74,300% | $1K0.0% | $1K0.0% | $1K-99.9% | ||
| $3.55M+49.3% | $2.38M+643% | $320K-86.6% | $2.38M+80.5% | $1.32M— | ||
| —— | —— | —— | —— | —— | ||
| $2M— | —— | —— | $6.46M— | —— | ||
| -$477K— | —— | $615K+487% | -$159K-312% | $75K-51.0% | ||
| -$434K— | $0+100% | -$399K-116% | $2.53M+395% | -$858K— | ||
| —— | $0— | $0— | $0— | $0— | ||
| $208.29M+216,864% | $96K+3.2% | $93K-98.6% | $6.79M-98.1% | $353.13M+284,684% | ||
| —— | $338K0.0% | $338K0.0% | $338K0.0% | $338K+68.8% | ||
| —— | $585.5K0.0% | $585.5K0.0% | $585.5K0.0% | $585.5K-11.6% | ||
| —— | $971.75K0.0% | $971.75K0.0% | $971.75K0.0% | $971.75K+356% | ||
| $131.6M— | —— | $200K-89.5% | $1.9M-17.4% | $2.3M— | ||
| —— | $850K0.0% | $850K0.0% | $850K0.0% | $850K+839% | ||
| -$1.14M— | —— | —— | —— | -$10.37M+52.2% | ||
| $119.9M+10,992% | -$1.1M-101% | $133.8M+33.6% | $100.13M+34.1% | $74.67M+45.0% | ||
| $187.05M+142% | $77.18M-64.8% | $218.96M-0.3% | $219.64M+12.6% | $195.03M+27.0% | ||
| $187.05M+142% | $77.18M-64.8% | $218.96M-0.3% | $219.64M+12.6% | $195.03M+27.0% | ||
| 18.8%+11.0pp | 7.8%-14.0pp | 21.8%+0.5pp | 21.3%+1.5pp | 19.8%+4.5pp | ||
| $119.9M+10,992% | -$1.1M-101% | $133.8M+33.6% | $100.13M+34.1% | $74.67M+45.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Charles River Laboratories's revenue?
- Charles River Laboratories (CRL) generated $4.0B in revenue over the trailing twelve months, up 0.1% year over year.
- Is Charles River Laboratories profitable?
- Charles River Laboratories is not currently profitable: it reported a net loss of $184.7M over the trailing twelve months, a -4.6% net margin.
- What are Charles River Laboratories's profit margins?
- Gross margin is 84.7% and operating margin is 13.0%, with a -4.6% net margin.
- What is Charles River Laboratories's earnings per share?
- Charles River Laboratories's diluted EPS over the trailing twelve months is $-3.70.
- Where does Charles River Laboratories's income statement data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
